proguanil has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, K; Felgenhauer, U; Han, N; Harris, R; Hwang, W; Kouzarides, T; Lei, W; Liu, A; M Katritsis, N; MacMahon, M; McCaughan, F; Schmerer, P; Schuldt, A; Tzelepis, K; Weber, F; Yankova, E | 1 |
1 other study(ies) available for proguanil and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Neural Networks, Computer; Proguanil; SARS-CoV-2; Sulfasalazine; Virus Replication | 2021 |